Posaconazole Tablet, Delayed Release
Product Images NDC 70377-038

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 70377-038). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocon Phama Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

60-tab-label (60 Tab Label)

This is a description of a drug called Posaconazole, which is available in delayed-release tablet form. Each tablet contains 100mg of the drug. The tablets are stored at a temperature between 20°C and 25°C and can have excursions between 15°C to 30°C. The usual dosage is mentioned in the package insert. The package is child-resistant. The oral suspension and delayed-release tablets of Posaconazole are not interchangeable due to dosage differences. The tablets are manufactured by Biocon Pharma Limited, Bengaluru, India, and are brought to the USA by Biocon Pharma Inc., Iselin, NJ. The trademarks mentioned belong to their respective companies.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.